These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15359939)

  • 1. [Coagulopathy in severe sepsis: is there anything new?].
    Samama M
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():34-5. PubMed ID: 15359939
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein C concentrate in adult septic patients.
    Betrosian AP; Memos N; Theoddossiades G; Douzinas EE
    Intensive Care Med; 2008 Oct; 34(10):1932. PubMed ID: 18629470
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation inhibitors in sepsis and disseminated intravascular coagulation.
    Lee WL; Downey GP
    Intensive Care Med; 2000 Nov; 26(11):1701-6. PubMed ID: 11193281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulopathy and the role of recombinant human activated protein C in sepsis and following polytrauma.
    Dahabreh Z; Dimitriou R; Chalidis B; Giannoudis PV
    Expert Opin Drug Saf; 2006 Jan; 5(1):67-82. PubMed ID: 16370957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation].
    Thachil J; Toh CH; Levi M; Watson HG
    Br J Haematol; 2012 May; 157(4):493-4. PubMed ID: 22225506
    [No Abstract]   [Full Text] [Related]  

  • 6. Current clinical practice. DIC 2002: a review of disseminated intravascular coagulation.
    Toh CH; Dennis M
    Hematology; 2003 Apr; 8(2):65-71. PubMed ID: 12745654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
    de Jonge E; van der Poll T; Kesecioglu J; Levi M
    Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drotrecogin alfa (activated) in an infant with gram-negative septic shock.
    Sajan I; Da-Silva SS; Dellinger RP
    J Intensive Care Med; 2004; 19(1):51-5. PubMed ID: 15035755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trials for severe sepsis/DIC].
    Kushimoto S
    Rinsho Byori; 2011 Feb; Suppl 147():85-94. PubMed ID: 21761754
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activated protein C and treatment of sepsis].
    Høibraaten E; Vangerow B
    Tidsskr Nor Laegeforen; 2004 May; 124(10):1422; author reply 1422-3. PubMed ID: 15195189
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of severe sepsis and multiple organ failure with activated protein C].
    Strøm JJ
    Ugeskr Laeger; 2004 Mar; 166(11):995. PubMed ID: 15049233
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
    Levi M
    J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation in sepsis: all bugs bite equally.
    Levi M; van der Poll T
    Crit Care; 2004 Apr; 8(2):99-100. PubMed ID: 15025767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein C concentrate as adjuvant treatment in neonates with sepsis-induced coagulopathy: a pilot study.
    Decembrino L; D'Angelo A; Manzato F; Solinas A; Tumminelli F; De Silvestri A; De Lazzari S; Padovani E; Magarotto M; Chiandetti L; Saia SO; Stronati M
    Shock; 2010 Oct; 34(4):341-5. PubMed ID: 20823695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human activated protein C in the treatment of severe sepsis: an evidence-based review.
    Fourrier F
    Crit Care Med; 2004 Nov; 32(11 Suppl):S534-41. PubMed ID: 15542961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human activated protein C (Xigris).
    Levi M; De Jonge E; van der Poll T
    Int J Clin Pract; 2002 Sep; 56(7):542-5. PubMed ID: 12296618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human activated protein C and strict glycemic control in sepsis: mutually exclusive strategies?
    Schultz MJ; Levi M
    Minerva Anestesiol; 2009; 75(7-8):415-6. PubMed ID: 19153552
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis].
    Heslet L; Nielsen JD; Schierbeck J; Andersen JS
    Ugeskr Laeger; 2004 Mar; 166(11):997-1002. PubMed ID: 15049234
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant human activated protein C for severe sepsis.
    Ott A; Verbrugh HA
    N Engl J Med; 2001 Jul; 345(3):220; author reply 220-1. PubMed ID: 11463023
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant human-activated protein C (rhAPC) in childhood sepsis.
    Frassica JJ; Vinagre YM; Maas B
    J Intensive Care Med; 2004; 19(1):56-7. PubMed ID: 15035756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.